President Donald Trump announced nine of the largest drugmakers in the U.S. and Europe agreed to voluntarily sell their ...
President Donald Trump has pushed to lower drug prices for Americans, which are on average nearly three times higher than ...
President Trump announced nine more companies joining TrumpRx, aiming for U.S.-Europe drug price parity using tariffs as leverage. TrumpRx will offer future drug releases at most-favored-nation ...
The White House announced Friday that nine additional pharmaceutical companies have agreed to follow President Trump’s Most ...
President Donald Trump signed an executive order Thursday to reclassify marijuana as a less dangerous drug, paving the way for more medical research ...
The New Republic on MSNOpinion
Turning Point USA Conference Erupts Into MAGA War Between Speakers
Right-wing commentators Ben Shapiro and Tucker Carlson used their speeches at Turning Point USA’s AmericaFest to take shots ...
The Justice Department faces a Friday deadline to release its files on Jeffrey Epstein, a convicted sex offender and wealthy financier known for his connections to some of the world’s most influential ...
The new tax, signed into law by Gov. Gretchen Whitmer in October, comes amid an industry conundrum, where prices are at historic lows due to an oversaturated market fueled by unlimited business ...
President Trump will make an announcement Friday afternoon related to lowering drug prices — an effort he has leaned into ...
On December 1, 2025, the Office of the United States Trade Representative, the Department of Commerce, and the Department of Health and Human Services announced an agreement with the United Kingdom (U ...
ABC News’ Linsey Davis spoke with Saphira Galoob, the executive director of the U.S. Cannabis Roundtable, about the significance of the executive order to reclassify marijuana as a Schedule III drug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results